2041. Impact of T2 Candida Panel on Species Specific Anti-fungal De-escalation

BACKGROUND: Empiric antifungal treatment is recommended in patients with suspected candidemia given the 20–40% associated mortality. T2Candida Panel (T2) is approved for the rapid detection directly on a blood sample of candidemia caused by C. albicans/C. tropicalis (CA/CT), C. parapsilosis (CP), C....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Forum Infect Dis
Autori principali: Chaudhry, Zohra, Vahia, Amit, Askar, Sally, Hussain, Noman, Hameed, Mujtaba, Alangaden, George
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6252867/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1697
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi